中华放射肿瘤学杂志
中華放射腫瘤學雜誌
중화방사종류학잡지
CHINESE JOURNAL OF RADIATION ONCOLOGY
2012年
2期
101-104
,共4页
曹才能%张希梅%罗京伟%徐国镇%高黎%易俊林%黄晓东%肖建平%李素艳
曹纔能%張希梅%囉京偉%徐國鎮%高黎%易俊林%黃曉東%肖建平%李素豔
조재능%장희매%라경위%서국진%고려%역준림%황효동%초건평%리소염
鼻咽涎腺型肿瘤/放射疗法%预后
鼻嚥涎腺型腫瘤/放射療法%預後
비인연선형종류/방사요법%예후
Nasopharynx salivary gland type neoplasm/radiotherapy%Prognosis
目的 分析原发鼻咽涎腺型癌临床特点、治疗方法及预后因素.方法 回顾分析1963-2006年本院收治的54例原发鼻咽涎腺型癌患者资料,其中腺样囊性癌36例、黏液表皮样癌11例、腺癌7例,单纯手术2例、单纯放疗30例、综合治疗22例(手术加放疗15例,放疗加手术7例).8例接受化疗(术后辅助化疗1例,同期放化疗1例,复发后化疗6例).用Logrank法单因素分析.结果 随访率为89%.2、5年总生存率分别为85%、61%,无局部区域失败生存率分别为74%、55%,无远处转移生存率分别为92%、70%.治疗失败35例,其中26例局部区域失败(1例鼻咽复发加颈部淋巴结转移,23例鼻咽复发,2例颈部淋巴结转移).发生远处转移13例(4例出现多脏器转移),其中肺转移10例、肝转移3例、骨转移2例、脑转移1例、皮下转移1例.单因素分析显示病理亚型与总生存率相关(x2=15.29,P=0.000),而颈部淋巴结转移与无远转生存率相关(x2=9.08,P=0.003).结论 鼻咽涎腺型癌是一种局部侵袭性强、病程发展相对较慢的疾病,治疗上推荐手术与放疗的综合治疗.
目的 分析原髮鼻嚥涎腺型癌臨床特點、治療方法及預後因素.方法 迴顧分析1963-2006年本院收治的54例原髮鼻嚥涎腺型癌患者資料,其中腺樣囊性癌36例、黏液錶皮樣癌11例、腺癌7例,單純手術2例、單純放療30例、綜閤治療22例(手術加放療15例,放療加手術7例).8例接受化療(術後輔助化療1例,同期放化療1例,複髮後化療6例).用Logrank法單因素分析.結果 隨訪率為89%.2、5年總生存率分彆為85%、61%,無跼部區域失敗生存率分彆為74%、55%,無遠處轉移生存率分彆為92%、70%.治療失敗35例,其中26例跼部區域失敗(1例鼻嚥複髮加頸部淋巴結轉移,23例鼻嚥複髮,2例頸部淋巴結轉移).髮生遠處轉移13例(4例齣現多髒器轉移),其中肺轉移10例、肝轉移3例、骨轉移2例、腦轉移1例、皮下轉移1例.單因素分析顯示病理亞型與總生存率相關(x2=15.29,P=0.000),而頸部淋巴結轉移與無遠轉生存率相關(x2=9.08,P=0.003).結論 鼻嚥涎腺型癌是一種跼部侵襲性彊、病程髮展相對較慢的疾病,治療上推薦手術與放療的綜閤治療.
목적 분석원발비인연선형암림상특점、치료방법급예후인소.방법 회고분석1963-2006년본원수치적54례원발비인연선형암환자자료,기중선양낭성암36례、점액표피양암11례、선암7례,단순수술2례、단순방료30례、종합치료22례(수술가방료15례,방료가수술7례).8례접수화료(술후보조화료1례,동기방화료1례,복발후화료6례).용Logrank법단인소분석.결과 수방솔위89%.2、5년총생존솔분별위85%、61%,무국부구역실패생존솔분별위74%、55%,무원처전이생존솔분별위92%、70%.치료실패35례,기중26례국부구역실패(1례비인복발가경부림파결전이,23례비인복발,2례경부림파결전이).발생원처전이13례(4례출현다장기전이),기중폐전이10례、간전이3례、골전이2례、뇌전이1례、피하전이1례.단인소분석현시병리아형여총생존솔상관(x2=15.29,P=0.000),이경부림파결전이여무원전생존솔상관(x2=9.08,P=0.003).결론 비인연선형암시일충국부침습성강、병정발전상대교만적질병,치료상추천수술여방료적종합치료.
Objective To analyze the clinical characteristics , therapeutic outcomes , and prognostic factors of primary salivary gland type nasopharyngeal carcinoma ( SNPC) . Methods The medical records of 54 patients with SNPC at single institution between 1963 and 2006 were reviewed, 2 patients received surgery alone, 30 patients received radiotherapy alone and 22 patients received combined modality therapy consisting of surgery (S) and radiotherapy ( RT) ( S + RT in 15 and RT + S in 7). Of them, 8 patients received chemotherapy , including post-operative adjuvant chemotherapy in 1 patient, palliative chemotherapy in 6 patients and concurrent chemotherapy in 1 patient. 36 patients had adenoid cystic carcinoma ( ACC) ,11 mucoepidermoid carcinoma ( MEC) , and 7 primary traditional adenocarcinoma ( AC) . The Kaplan-Meier method was used to calculate the overall sunival ( OS) , locoregional failure-free survival ( LRFFS) , and distant failure-free survival ( DFFS) rates. Univariate analyses were performed using the Log-rank method.Comparisons of variables between cases were performed using Pearson chi-square test. Results The follow-up was 89% . The 2-, and 5-year overall survival rates, loco-regional failure free survival rates and distant failure free survival rates were 85% and 61% , 74% and 55% , 92% and 70%, respectively. Among the 35 patients with treatment failure, 26 patients had locoregional failure (1 in primary site and cervical lymph node ,23 in primary site and 2 in cervical lymph node) ,and 13 had distant metastasis. The lung was the most common site of metastasis ( n =10) , followed by liver (n = 3), bone ( n = 2) , brain ( n = 1) , and subcutaneous tissue ( n = 1) . Univariate analyses indicated that histological subtypes correlated with overall survival ( X2 = 15. 29, P = 0. 000) and cervial lymph node metastases correlated with distant failure-free survival ( X2 =9. 08 ,P = 0. 003) . Conclusions Primary salivary gland type nasopharyngeal carcinoma is a locally aggressive disease with a long course. The optimal treatment policy for patients with SNPC may be surgery plus radiotherapy.